TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ORGO

Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ -2.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Organogenesis Holdings Inc (ORGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 563 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ORGO
Line item 2001 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1.0 99 0.0 0.0 193 261 338 467 451 433 482 563
1.2 46 0.2 4.6 69 76 87 114 105 106 116 138
-0.2 53 -0.2 -4.6 125 185 251 353 346 327 366 426
1.6 3.9 6.3 9.1 11 15 20 31 40 44 50 45
0.8 0.0 0.2 4.6 162 199 201 245 279 265 291 326
3.6 125 0.2 204 173 215 224 281 324 314 368 370
-2.6 0.0 0.2 -4.6 -52 -30 27 72 22 13 -1.3 56
0.0 0.0 5.6 2.5 11 9.0 11 7.2 2.0 2.2 1.5 2.3
-2.9 0.0 -0.2 -2.1 -65 -39 18 63 20 10 -2.8 47
0.0 -0.2 -0.4 -7.0 0.1 0.2 0.5 -31 4.8 5.4 -3.7 9.9
-2.9 0.0 -0.2 -2.1 -65 -39 17 94 16 4.9 0.9 37
7.1 -4.6 -47 -20 37 87 40 36 16 74

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?